321 related articles for article (PubMed ID: 23589494)
1. Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia.
Díaz B; Yuen A; Iizuka S; Higashiyama S; Courtneidge SA
J Cell Biol; 2013 Apr; 201(2):279-92. PubMed ID: 23589494
[TBL] [Abstract][Full Text] [Related]
2. Mitogen-activated protein kinase (MAPK) regulates leukotriene D4-induced HB-EGF and ADAM12 expression in human airway smooth muscle cells.
Kumasawa F; Hashimoto S; Mizumura K; Takeshita I; Onose A; Jibiki I; Maruoka S; Gon Y; Kobayashi T; Takahashi N
Asian Pac J Allergy Immunol; 2013 Mar; 31(1):58-66. PubMed ID: 23517395
[TBL] [Abstract][Full Text] [Related]
3. PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor.
Mori S; Tanaka M; Nanba D; Nishiwaki E; Ishiguro H; Higashiyama S; Matsuura N
J Biol Chem; 2003 Nov; 278(46):46029-34. PubMed ID: 12952982
[TBL] [Abstract][Full Text] [Related]
4. Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.
Shimura T; Kataoka H; Ogasawara N; Kubota E; Sasaki M; Tanida S; Joh T
Clin Cancer Res; 2008 Jun; 14(12):3956-65. PubMed ID: 18559618
[TBL] [Abstract][Full Text] [Related]
5. Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain.
Miller MA; Moss ML; Powell G; Petrovich R; Edwards L; Meyer AS; Griffith LG; Lauffenburger DA
Sci Rep; 2015 Oct; 5():15150. PubMed ID: 26477568
[TBL] [Abstract][Full Text] [Related]
6. The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis.
Rocks N; Estrella C; Paulissen G; Quesada-Calvo F; Gilles C; Guéders MM; Crahay C; Foidart JM; Gosset P; Noel A; Cataldo DD
Cell Prolif; 2008 Dec; 41(6):988-1001. PubMed ID: 19040574
[TBL] [Abstract][Full Text] [Related]
7. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.
Higashiyama S; Nanba D
Biochim Biophys Acta; 2005 Aug; 1751(1):110-7. PubMed ID: 16054021
[TBL] [Abstract][Full Text] [Related]
8. Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition.
Yagi H; Yotsumoto F; Miyamoto S
Mol Cancer Ther; 2008 Oct; 7(10):3441-51. PubMed ID: 18852147
[TBL] [Abstract][Full Text] [Related]
9. PKCα and PKCδ regulate ADAM17-mediated ectodomain shedding of heparin binding-EGF through separate pathways.
Kveiborg M; Instrell R; Rowlands C; Howell M; Parker PJ
PLoS One; 2011 Feb; 6(2):e17168. PubMed ID: 21386996
[TBL] [Abstract][Full Text] [Related]
10. [Membrane-anchored heparin-binding EGF-like growth factor processing by ADAM12 in cardiac hypertrophy].
Higashiyama S
Nihon Rinsho; 2003 May; 61(5):767-75. PubMed ID: 12755001
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic processing of delta-like 1 by ADAM proteases.
Dyczynska E; Sun D; Yi H; Sehara-Fujisawa A; Blobel CP; Zolkiewska A
J Biol Chem; 2007 Jan; 282(1):436-44. PubMed ID: 17107962
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor.
Kuo PL; Huang MS; Cheng DE; Hung JY; Yang CJ; Chou SH
J Biol Chem; 2012 Mar; 287(13):9753-9764. PubMed ID: 22291012
[TBL] [Abstract][Full Text] [Related]
13. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
Asakura M; Kitakaze M; Takashima S; Liao Y; Ishikura F; Yoshinaka T; Ohmoto H; Node K; Yoshino K; Ishiguro H; Asanuma H; Sanada S; Matsumura Y; Takeda H; Beppu S; Tada M; Hori M; Higashiyama S
Nat Med; 2002 Jan; 8(1):35-40. PubMed ID: 11786904
[TBL] [Abstract][Full Text] [Related]
14. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.
Ebi M; Kataoka H; Shimura T; Kubota E; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Mabuchi M; Tsukamoto H; Tanida S; Kamiya T; Higashiyama S; Joh T
Biochem Biophys Res Commun; 2010 Nov; 402(3):449-54. PubMed ID: 20934403
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis.
Wang R; Godet I; Yang Y; Salman S; Lu H; Lyu Y; Zuo Q; Wang Y; Zhu Y; Chen C; He J; Gilkes DM; Semenza GL
Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33952697
[TBL] [Abstract][Full Text] [Related]
16. Wound-induced ATP release and EGF receptor activation in epithelial cells.
Yin J; Xu K; Zhang J; Kumar A; Yu FS
J Cell Sci; 2007 Mar; 120(Pt 5):815-25. PubMed ID: 17284517
[TBL] [Abstract][Full Text] [Related]
17. ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding.
Yin J; Yu FS
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):132-9. PubMed ID: 18658095
[TBL] [Abstract][Full Text] [Related]
18. Insulin-induced epidermal growth factor activation in vascular smooth muscle cells is ADAM-dependent.
Roztocil E; Nicholl SM; Davies MG
Surgery; 2008 Aug; 144(2):245-51. PubMed ID: 18656632
[TBL] [Abstract][Full Text] [Related]
19. Extracellular engagement of ADAM12 induces clusters of invadopodia with localized ectodomain shedding activity.
Albrechtsen R; Stautz D; Sanjay A; Kveiborg M; Wewer UM
Exp Cell Res; 2011 Jan; 317(2):195-209. PubMed ID: 20951132
[TBL] [Abstract][Full Text] [Related]
20. Role of hypoxia-related proteins in invasion of ameloblastoma cells: crosstalk between NOTCH1, hypoxia-inducible factor 1α, a disintegrin and metalloproteinase 12, and heparin-binding epidermal growth factor.
da Costa NM; Fialho AD; Proietti CC; da Silva Kataoka MS; Jaeger RG; de Alves-Júnior SM; de Jesus Viana Pinheiro J
Histopathology; 2016 Jul; 69(1):99-106. PubMed ID: 26707922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]